Needham analyst Mike Cikos maintains GitLab (NASDAQ:GTLB) with a Buy and lowers the price target from $70 to $60.
Quanterix’s Simoa Technology Drives Advances In Alzheimer’s Disease Research Presented At 2022 Clinical Trials On Alzheimer’s Disease Conference
Quanterix Corporation (NASDAQ:QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances in ongoing
